Has anyone thoughts on how the CellPryme assett will be converted to revenue. How do you quantify a charge to 3rd parties under a licensing agreement. Upfront license fee and then a royalty?? fee. Any stabs at quantifying this revenue stream
Has anyone thoughts on how the CellPryme assett will be...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.001(2.13%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.7¢ | 4.6¢ | $3.926K | 84.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 214412 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 59748 | 2 |
View Market Depth
| Last trade - 10.25am 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.5¢ |
Change
-0.001 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 4.6¢ | 4.5¢ | 121915 | ||
| Last updated 11.10am 05/06/2024 ? | |||||
| PTX (ASX) Chart |